Stamford, CT -- (SBWIRE) -- 01/24/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Tranzbyte Corp (OTCMKTS:ERBB), CEL-SCI Corporation (NYSEMKT:CVM), Exelixis, Inc. (NASDAQ:EXEL), American Realty Capital Properties Inc (NASDAQ:ARCP).
Tranzbyte Corp (OTCMKTS:ERBB) opened its last trade at the price of $0.01. Its closing price was $0.0115 after gaining 57.53% for the day. The company traded with the total volume of 559.48 million shares, while its average trading volume remained 133.19 million shares. The beta of this stock stands at 7.61. Tranzbyte Corporation operates medical marijuana retail dispensaries under the Altitude Organic Medicine brand name in California, Colorado, and Arizona. The company also produces a portfolio of RFID readers, tags, sensor tags, sensor probes, and RFID-enabled data logging tags.
For How Long ERBB will Fight for Profitability? Read This Trend Analysis report
CEL-SCI Corporation (NYSEMKT:CVM) percentage change surged 12.62% to close at $1.16 with the total traded volume of 11.62 million shares, along with average volume of 1.81 million shares. The 52 week range of the stock remained $0.53 - $3.09, while its day lowest price was $1.06. The share price hit the day highest price of $1.17. CEL-SCI Corporation is engaged in the research and development of drugs and vaccines. The company’s lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. Multikine is also being used in a Phase I study with the Naval Medical Center.
Will CVM Continue To Move Higher? Find Out Here
Exelixis, Inc. (NASDAQ:EXEL) traded on volume of 18.67 million shares in the last session against average volume of 2.44 million shares. The company started its trading session with the price of $8.18 and closed at $8.01 by scoring -0.37%. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer.
Why Should Investors Buy EXEL After the Recent Fall? Just Go Here and Find Out
American Realty Capital Properties Inc (NASDAQ:ARCP) started its last trading session with the price of $13.93 and closed at $14.21 by scoring 1.86%. The stock traded with total volume of 26.42 million shares, while the average trading volume remained 6.14 million shares. Day range for the stock was $13.89 - $14.23. American Realty Capital Properties, Inc. owns and acquires single tenant, freestanding commercial real estate that is net leased on a medium-term basis, primarily to investment grade credit rated and other creditworthy tenants.
For How Long ARCP will Fight for Profitability? Read This Trend Analysis report
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)